Publication: Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases
Issued Date
2019-01-01
Resource Type
ISSN
21565376
21618313
21618313
Other identifier(s)
2-s2.0-85061474121
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Advances in Nutrition. Vol.10, No.1 (2019), 112-121
Suggested Citation
Rattiyaporn Kanlaya, Visith Thongboonkerd Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases. Advances in Nutrition. Vol.10, No.1 (2019), 112-121. doi:10.1093/advances/nmy077 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/49870
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases
Author(s)
Other Contributor(s)
Abstract
© 2019 American Society for Nutrition. All rights reserved. Kidney diseases are common health problems worldwide. Various etiologies (e.g., diabetes, hypertension, drug-induced nephrotoxicity, infection, cancers) can affect renal function and ultimately lead to development of chronic kidney disease (CKD) and end-stage renal disease (ESRD). The global rise in number of CKD/ESRD patients during recent years has led to tremendous concern to look for effective strategies to prevent or slow progression of CKD and ESRD. Natural compounds derived from herbs or medicinal plants have gained wide attention for scientific scrutiny to achieve such goals. One of such natural compounds that has been extensively investigated is epigallocatechin-3-gallate (EGCG), a major polyphenol found in the tea plant (Camellia sinensis). A growing body of recent evidence has shown that EGCG may be a promising therapeutic or protective agent in various kidney diseases. This article thus highlights recent progress in medical research on beneficial effects of EGCG against a broad spectrum of kidney diseases, including acute kidney injury, cisplatin-induced nephrotoxicity, kidney stone disease, glomerulonephritis, lupus nephritis, renal cell carcinoma, diabetic nephropathy, CKD, and renal fibrosis. The renoprotective mechanisms are also detailed. Finally, future perspectives of medical research on EGCG and its potential use in clinical practice for treatment and prevention of kidney diseases are discussed.